Lower C-reactive protein level seen with self-monitoring program

03/8/2013 | PhysiciansBriefing.com

Data on 483 patients with poorly controlled, insulin-naive type 2 diabetes showed those in a structured intervention for self-monitoring of their blood glucose levels attained greater reductions in their level of high-sensitivity C-reactive protein at three, six and 12 months compared with those in the control group. The results appear in Diabetes Care.

View Full Article in:

PhysiciansBriefing.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA